Compare companies

Pick 2–4 companies for a side-by-side spec sheet.

Selected: 1 / 4

Side by side

FieldFreenome
Categories
HQSan Francisco, United States
Founded2014
Latest valuation
Annual Recurring Revenue (ARR)
Funding to date$1.4B+
Headcount
Profitability
Statusactive
Pricing tierenterprise
DescriptionFreenome develops AI-powered blood tests for early cancer detection through machine learning analysis of circulating tumor DNA and proteins. The company has raised $1.4B cumulatively, targeting cancer diagnostics at the earliest disease stages.